SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Malaviya AN (2003) Rheumatology in the Asia-Pacific Region: Unmet Needs Challenges (the Feng Pao Hsii Lecture). APLAR J Rheumatol 6, 6472.
  • 2
    Lawrence RC, Helmick CG, Arnett FC, et al. (1998) Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum 41, 77899.
  • 3
    Dequeker J, Rasker JJ, Woolf AD (2000) Educational issues in rheumatology. Bailliere's Best Pract Res Clin Rheumatol 14, 71529.
  • 4
    Dequeker J, Rasker H (1998) High prevalence and impact of rheumatic diseases is not reflected in the medical curriculum: The ILAR Undergraduate Medical Education in Rheumatology (UMER) 2000 Project. Together everybody achieves more. J Rheumatol 25, 103740.
  • 5
    Smolen JS (2004) Combating the burden of musculoskeletal diseases. Ann Rheum Dis 63, 329.
  • 6
    Freedman KB, Bernstein J (2002) Educational deficiencies in musculoskeletal medicine. J Bone Joint Surg Am 84-A: 604–8.
  • 7
    Freedman KB, Bernstein J (1998) The adequacy of medical school education in musculoskeletal medicine. J Bone Joint Surg Am 80, 14217.
  • 8
    Gamez-Nava JI, Gonzalez-Lopez L, Davis P, Suarez-Almazor ME (1998) Referral and diagnosis of common rheumatic diseases by primary care physicians. Br J Rheumatol 37, 12159.
  • 9
    Woolf AD, Walsh NE, Akesson K (2004) Global core recommendations for a musculoskeletal undergraduate curriculum. Ann Rheum Dis 63, 51724.
  • 10
    Weinblatt ME (2002) The best of times, the worst of times: rheumatology 2001. Arthritis Rheum 46, 56773.
  • 11
    Pincus T, Gibofsky A, Weinblatt ME (2002) Urgent care and tight control of rheumatoid arthritis as in diabetes and hypertension: better treatments but a shortage of rheumatologists. Arthritis Rheum 46, 8514.
  • 12
    O'Dell JR (2002) Treating rheumatoid arthritis early: a window of opportunity? Arthritis Rheum 46, 2835.
  • 13
    Criswell LA, Such CL, Yelin EH (1997) Differences in the use of second-line agents and prednisone for treatment of rheumatoid arthritis by rheumatologists and non-rheumatologists. J Rheumatol 24, 228390.
  • 14
    Solomon DH, Bates DW, Panush RS, Katz JN (1997) Costs, outcomes, and patient satisfaction by provider type for patients with rheumatic and musculoskeletal conditions: a critical review of the literature and proposed methodologic standards. Ann Intern Med 127, 5260.
  • 15
    Anderson JJ, Wells G, Verhoeven AC, Felson DT (2000) Factors predicting response to treatment in rheumatoid arthritis: the importance of disease duration. Arthritis Rheum 43, 229.
  • 16
    Doherty M, Abawi J, Pattrick M (1990) Audit of medical inpatient examination: a cry from the joint. J R Coll Phy Lond 24, 1158.
  • 17
    Courtney PA, Wright GD (2001) Referrals . . . are they appropriate? Ann Rheum Dis 60, 9912.
  • 18
    ‘Rheumawire’ Report (‘Rheumatalk’). April 10, 2002 ‘Residents inadequately trained in musculoskeletal medicine’ Posted on the official website of ‘Joint and Bone’: jointandbone.org
  • 19
    Harris ED Jr (2000) The Initial Evaluation: An approach to rapid diagnosis. In: HarrisEDJr, GenoveseMC (eds) Primary Care Rheumatology, pp. 1322. Saunders, Philadelphia.
  • 20
    (1997) Lipsky's ‘Algorithms for the diagnosis and management of musculoskeletal complaints’. Am J Med 103: 51S.
  • 21
    Malaviya AN, Kumar A. (1997) Polyarthritis: a clinical approach. J Assoc Physicians Ind 45, 558.
  • 22
    Malaviya AN (1999) Diagnosing arthritis in adults – an algorithmic approach. J Ind Rheumat Assoc 7, 97104.
  • 23
    Kumar A. ‘Approach to Arthritis’ In: Souvenir: ‘Rheumatology Update’ 4–5 August 2001, Ed. Col. VP Chaturvedi, Department of Rheumatology, Army Hospital (Research & Referral), Delhi Cantt.
  • 24
    Pincus T (1994) Rheumatoid arthritis: a medical emergency? Scand J Rheumatol Suppl 100, 2130.
  • 25
    Moreland LW, Bridges SL (2001) Early rheumatoid arthritis. A medical emergency? Am J Med 111, 498500.
  • 26
    Plant MJ, Jones PW, Saklatvala J, Ollier WE, Dawes PT (1998) Patterns of radiological progression in early rheumatoid arthritis: Results of an 8 year prospective study. J Rheumatol 25, 41726.
  • 27
    Pincus T, Callahan LF (1990) Remodelling the pyramid or remodelling the paradigms concerning rheumatoid arthritis: lessons from Hodgkin's disease and coronary artery disease. J Rheumatol 17, 15825.
  • 28
    McCarty DJ (1990) Suppress rheumatoid arthritis early and leave the pyramid for the Egyptians. J Rheumatol 17, 11158.
  • 29
    Mullan RH, Bresnihan B (2003) Disease-modifying anti-rheumatic drug therapy and structural damage in early rheumatoid arthritis. Clin Exp Rheumatol 21(5 Suppl 31), S15864.
  • 30
    Korpela M, Laasonen L, Hannonen P, et al. (2004) Retardation of joint damage in patients with early rheumatoid arthritis by initial aggressive treatment with disease-modifying antirheumatic drugs: Five-year experience from the FIN-RACo study. Arthritis Rheum 50, 207281.
  • 31
    Wick MC, Anderwald C, Weiss RJ, Imhof H, Kainberger F, Smolen JS (2004) Radiological progression of joint damage in a longitudinal cohort of early DMARD-treated rheumatoid arthritis patients followed for 10 years. Scand J Rheumatol 33, 1626.
  • 32
    Lard LR, Visser H, Speyer I, et al. (2001) Early versus delayed treatment in patients with recent-onset rheumatoid arthritis: comparison of two cohorts who received different treatment strategies. Am J Med 111, 44651.
  • 33
    American College of Rheumatology (2002) American College of Rheumatology – Guidelines for the management of rheumatoid arthritis: 2002 Update. Arthritis Rheum 46, 32846.
  • 34
    Gossec L, Dougados M (2003) Combination therapy in early rheumatoid arthritis. Clin Exp Rheumatol 21, S1748.
  • 35
    O'Dell JR (2004) Therapeutic strategies for rheumatoid arthritis. New Engl J Med 350, 2591602.
  • 36
    Olsen NJ, Stein CM (2004) New drugs for rheumatoid arthritis. N Engl J Med 350, 216779.
  • 37
    Rahman A, Ahmed S, Underwood M (2001) Disease-modifying drugs in rheumatoid arthritis. Practitioner 245, 101825.
  • 38
    Kremer JM, Genovese MC, Cannon GW, et al. (2002) Concomitant leflunomide therapy in patients with active rheumatoid arthritis despite stable doses of methotrexate. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 137, 72633.
  • 39
    Cronstein BN (2004) Therapeutic cocktails for rheumatoid arthritis: Mixmaster's guide. Arthritis Rheum 50, 20413.
  • 40
    Edwards JCW, Szczepanski L, Szechinski J, et al. (2004) Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis. New Engl J Med 350, 257281.